MedPath

Psychological Symptoms in Cardiac and Pulmonary Diseases

Completed
Conditions
Psychological Distress
Anxiety
Cardiovascular Diseases
Depression
Rehabilitation
Coping Behavior
Pulmonary Disease
Interventions
Other: no intervention because it is an observational study
Registration Number
NCT06396793
Lead Sponsor
Istituti Clinici Scientifici Maugeri SpA
Brief Summary

The European guidelines emphasize the importance of conducting psychological screenings to investigate the presence of stress and symptoms of anxiety and depression in patients with cardiovascular disease: depression, common among patients with CVD, is associated with increased mortality, disability, decreased adherence to healthy lifestyles and medical treatments, and together with anxiety, the risk of mortality increases by about 3 times; stress, furthermore, is associated with the development and progression of cardiovascular diseases and is correlated with low adherence and cigarette smoking.

Less studied, but not less important, are the incidence of anxiety, depression, and stress in pulmonary disease, the relationship between mental disorders and pulmonary diseases, as well as the effect of the psychological component on the rehabilitative outcome of such patients: for example, there is evidence that those suffering from chronic obstructive pulmonary disease (COPD) present symptoms of depression and anxiety much more frequently than the general population and that these two mental disorders may exacerbate COPD itself.

The literature, therefore, highlights that the risk of onset of cardiovascular disease increases with the severity of mental disorder, and some psychological variables correlate with the outcomes of cardiac rehabilitation intervention, crucial for reducing rehospitalizations, myocardial infarction, and mortality, as well as for improving the patient's quality of life and ability to perform physical exercises.

In light of this evidence and the recent recommendations of the ESC, the present study aims to conduct screening for symptoms of anxiety, depression, and stress in all patients admitted to the Cardiology and Pulmonary Rehabilitation Units of the Milan Center, Camaldoli in order to assess their incidence and to select, through validated tools, patients who require personalized psychological intervention based on their level of risk, correlating then the presence of such symptoms with the rehabilitative outcome, in order to assess how much the mental component interferes with the care pathway. The level of acceptance and feasibility of a computerized data collection procedure will also be evaluated, a procedure that, if well accepted, would make the screening process much simpler, safer, and more economical.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
421
Inclusion Criteria
  • aged≥18
  • able to fulfil questionnaires autonomously
Exclusion Criteria
  • no Italian comprehension,
  • severe visuoperceptive deficits,
  • cognitive deterioration preventing self-completion of questionnaires,
  • refusal to underwent to the evaluation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cardio-respiratoryno intervention because it is an observational studyInpatients affected by cardiac or pulmonary diseases undergoing a rehabilitative program
Primary Outcome Measures
NameTimeMethod
Prevalence of psychological risk and protective factors18 months

To conduct a screening of anxious, depressive, stress symptoms and coping strategies in patients admitted a Cardiology and pulmonary Rehabilitation Units

Secondary Outcome Measures
NameTimeMethod
Correlations between psychological variables and rehabilitative outcomes18 months

To correlate risk and protective factors with rehabilitative outcomes

Acceptance of computerized screening18 months

The degree of acceptance of an online data collection procedure will be evaluated.

Trial Locations

Locations (1)

ICS Maugeri SpA SB

🇮🇹

Milan, MI, Italy

© Copyright 2025. All Rights Reserved by MedPath